Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tofacitinib for vitiligo
IRCT20150825023753N27Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vitiligo comparing Topical tofacitinib side with Topical placebo side (2 arms). Primary endpoints: Vitiligo Area Scoring Index, Visual analog scale and 3 more. Started May 2025; status: completed.
02
Drugs
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20150825023753N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150825023753N27.